≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Pneumoconiosis due to asbestos and other mineral fibres

DOID EFO Endpoint Browser PheWeb

J10_ASBESTPNEUMOC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J61
  • Hospital discharge: ICD-9 — 501
  • Hospital discharge: ICD-8 — 5152
  • Cause of death: ICD-10 — J61
  • Cause of death: ICD-9 — 501
  • Cause of death: ICD-8 — 5152

2 out of 7 registries used, show all original rules.

824

4. Check minimum number of events

None

824

5. Include endpoints

None

824

6. Filter based on genotype QC (FinnGen only)

824

Control definitions (FinnGen only)

Control exclude
J10_EXTERLUNG

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J60-J70
Name in latin
Asbestosis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6025 326 5496
Only index persons 3520 209 3311
Unadjusted period prevalence (%)
Whole population 0.15 0.01 0.15
Only index persons 0.12 0.01 0.13
Median age at first event (years)
Whole population 71.18 71.89 71.13
Only index persons 71.74 71.88 71.73

-FinnGen-

Key figures

All Female Male
Number of individuals 824 32 792
Unadjusted period prevalence (%) 0.34 0.01 0.35
Median age at first event (years) 70.27 61.36 70.63

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
736
Matched controls
7358
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
86.7
323.0
445
127
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
13226.5
323.0
676
5
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
+∞
85.1
80
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.9
77.6
158
180
XG410
NOMESCO Finland
Flow-volume spirometry
9.8
60.8
130
158
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
13.3
58.1
105
91
R03AC02
ATC
salbutamol; inhalant
3.4
54.0
424
2097
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.4
49.2
208
603
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
9.4
46.4
100
121
R03BB04
ATC
tiotropium bromide; inhalant
3.8
45.4
230
779
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.6
45.1
178
478
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.2
38.9
265
1104
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.7
37.4
115
231
H02AB06
ATC
prednisolone; systemic
2.5
31.0
409
2454
R06.0
ICD-10 Finland
Dyspnoea
2.7
30.2
264
1251
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
8.0
30.1
70
95
Z57.2
ICD-10 Finland
Occupational exposure to dust
24.0
29.0
41
18
J92.9
ICD-10 Finland
Pleural plaque without asbestos
9.7
28.2
58
64
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
16.4
26.2
42
27
TGC00
NOMESCO Finland
Bronchial lavation
7.3
26.0
64
95
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
16.4
24.4
39
25
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.1
24.3
155
590
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
24.0
88
212
J45.9
ICD-10 Finland
Asthma, unspecified
2.9
23.3
160
638
J96.1
ICD-10 Finland
Chronic respiratory failure
5.1
23.0
75
159
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
21.1
375
2413
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.7
21.1
169
739
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.4
20.0
205
1017
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.1
19.5
115
411
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
6.5
18.6
49
80
R03BA05
ATC
fluticasone; inhalant
2.6
17.7
141
607
R03BA01
ATC
beclometasone; inhalant
2.7
17.6
129
529
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.1
17.2
55
115
J45.1
ICD-10 Finland
Nonallergic asthma
3.7
16.4
74
215
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
61.3
15.8
18
*
R03BB01
ATC
ipratropium bromide; inhalant
2.9
15.1
100
384
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
9.7
14.5
29
31
1240
FHL
Bronchoscopy
5.9
14.1
39
69
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
5.2
14.0
43
86
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
16.6
13.5
21
13
J01AA02
ATC
doxycycline; systemic
1.9
13.5
519
4134
R04.2
ICD-10 Finland
Haemoptysis
3.5
12.9
61
185
GD1AD
NOMESCO Finland
Thorax CT examination
3.9
12.9
53
143
R03BA02
ATC
budesonide; inhalant
2.3
12.6
128
619
Z57.3
ICD-10 Finland
Occupational exposure to other air contaminants
71.1
12.6
14
*
J92
ICD-10 Finland
Pleural plaque
32.6
12.6
16
5
R03DA04
ATC
theophylline; systemic, rectal
2.4
12.6
111
500
51520
ICD-8 Finland
Pneumoconiosis due to silica and silicates, Asbestosis
+∞
12.5
12
*
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.2
12.3
46
114
R03AK07
ATC
formoterol and budesonide; inhalant
2.3
12.1
120
573
GAC00
NOMESCO Finland
Biopsy of pleura
21.7
12.0
17
8
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
11.4
98
435
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.0
11.3
67
240
R03AC03
ATC
terbutaline; inhalant
2.4
11.2
100
453
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
4.9
11.0
35
74
R05
ICD-10 Finland
Cough
2.2
10.9
127
649
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.3
297
2092
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.2
10.3
31
62
XG466
NOMESCO Finland
Sleep oxymetry
4.0
10.1
40
105
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.9
10.1
62
227
R06.2
ICD-10 Finland
Wheezing
3.6
9.8
44
129
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
10.8
9.8
18
17
R03BA08
ATC
ciclesonide; inhalant
3.2
9.8
51
168
R03AC13
ATC
formoterol; inhalant
3.0
9.6
56
199
J94.8
ICD-10 Finland
Other specified pleural conditions
4.8
9.4
30
64
R03AC12
ATC
salmeterol; inhalant
2.7
9.3
65
257
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
8.1
8.9
19
24
H02AB04
ATC
methylprednisolone; systemic
2.1
8.9
107
556
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
8.7
139
805
J47
ICD-10 Finland
Bronchiectasis
4.3
8.5
30
72
R02
ICPC
Shortness of breath/dyspnoea
2.1
8.4
95
480
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
8.3
260
1846
WX725
NOMESCO Finland
Noninvasive ventilation
3.3
8.2
39
121
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
3.5
8.1
37
111
C03CA01
ATC
furosemide; systemic
1.6
8.1
348
2669
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
8.3
8.1
17
21
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.4
8.0
20
32
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
9.5
7.8
15
16
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.7
7.6
160
1009
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
5.8
7.6
20
35
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.6
7.3
24
54
XG405
NOMESCO Finland
Education on PEF monitoring
5.9
7.3
19
33
5188X
ICD-9 Finland
Other diseases of lung
7.4
7.2
16
22
Y96.0
ICD-10 Finland
Work-related condition
20.2
7.1
10
5
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.1
7.1
26
65
J01FA06
ATC
roxithromycin; oral
1.6
7.1
246
1777
R99
ICPC
Respiratory disease other
5.7
7.1
19
34
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
6.9
116
683
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.7
6.9
44
167
R03DC03
ATC
montelukast; oral
2.2
6.9
70
340
N02AX02
ATC
tramadol; systemic, rectal
1.5
6.8
288
2178
G47.3
ICD-10 Finland
Sleep apnoea
1.8
6.6
123
744
J96.0
ICD-10 Finland
Acute respiratory failure
4.6
6.5
21
47
J62.0
ICD-10 Finland
Pneumoconiosis due to talc dust
+∞
6.3
6
*
J62.8
ICD-10 Finland
Pneumoconiosis due to other dust containing silica
+∞
6.3
6
*
R95
ICPC
Chron obstructive pulmonary disease
2.7
6.0
39
149
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
4.6
6.0
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019060) Gas panel - Arterial blood
123
545
2.48
17.24
4.5
3.7
—
—
—
0
0
(3009343) pH of Capillary blood
113
509
2.41
15.21
7.3
3.8
ph
7.4
7.4
0.65
14
54
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
108
486
2.41
14.55
7.5
3.7
mmol/l
2.5
1.8
1.08
87
344
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
112
515
2.36
14.37
7.5
3.8
kpa
5.5
5.1
2.78
104
462
(3023419) Bacteria identified in Sputum by Culture
38
93
4.24
14.33
2.8
2.4
—
—
—
0
0
(4010399)
88
363
2.59
14.25
1.4
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
76
291
2.78
14.25
9.0
4.3
mmol/l
26.0
24.6
2.83
69
263
(3022313) Gas panel - Capillary blood
89
370
2.58
14.19
7.6
4.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
72
285
2.67
12.65
3.4
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
51
5.02
11.74
3.6
3.4
—
—
—
0
0
(3000492) Spirometry study
76
351
2.28
9.60
1.8
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
266
1850
1.65
9.57
6.2
5.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
44
161
2.83
9.00
1.9
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
147
883
1.81
8.94
6.5
6.5
kpa
10.1
11.4
3.06
139
834
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
147
883
1.81
8.94
6.5
6.5
kpa
5.2
5.0
1.48
139
836
(3003396) Base excess in Arterial blood by calculation
143
882
1.75
7.90
6.6
6.5
mmol/l
1.8
1.2
1.13
110
658
(4015189)
14
24
5.92
7.87
1.9
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
155
2.66
7.38
2.0
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
342
2644
1.50
7.29
5.9
5.0
e9/l
0.2
0.2
0.04
298
2298
(3006315) Basophils [#/volume] in Blood
332
2557
1.50
7.17
5.4
4.9
e9/l
0.0
0.0
1.05
285
2192
(3001604) Monocytes [#/volume] in Blood
331
2548
1.50
7.17
5.4
4.9
e9/l
0.7
0.7
2.61
284
2168
(1616796) Gas panel - Central venous blood
43
178
2.49
6.96
3.5
3.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
94
532
1.87
6.87
1.3
1.2
iu/ml
23.5
46.4
2.58
29
158
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
58
3.69
6.78
1.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
58
3.69
6.78
1.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
58
3.69
6.78
1.2
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
111
2.86
6.64
3.3
2.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
334
2606
1.47
6.63
5.4
5.1
e9/l
1.8
1.8
0.01
289
2269
(3016502) Oxygen saturation in Arterial blood
128
805
1.70
6.54
6.6
6.8
%
93.3
94.8
1.63
122
770
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
73
392
1.95
6.26
6.3
9.4
mmol/l
25.1
24.2
1.67
62
361
(3037522) Nuclear Ab [Titer] in Serum
81
451
1.88
6.23
1.2
1.2
titre
288.7
423.7
0.79
23
103
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
299
2316
1.46
6.02
4.6
3.4
ng/l
2317.0
2592.9
0.47
270
2050
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
59
3.45
5.89
1.6
1.9
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
86
2.97
5.77
3.1
2.5
mg/l
28.5
26.1
—
6
17
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
17
5.94
5.63
1.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
61
3.34
5.61
1.7
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
30
116
2.65
5.61
1.6
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
303
2379
1.43
5.58
6.5
5.2
%
0.6
0.6
0.13
280
2218
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
77
3.04
5.56
3.4
3.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
48
3.60
5.34
2.6
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
90
2.83
5.34
1.9
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
90
2.83
5.34
1.2
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
106
670
1.67
5.30
5.1
4.9
%
34.1
32.9
0.40
66
440
(3019069) Monocytes/100 leukocytes in Blood
307
2453
1.40
4.99
6.6
5.4
%
9.6
9.2
0.84
282
2287
(3002030) Lymphocytes/100 leukocytes in Blood
311
2491
1.40
4.98
6.6
5.5
%
23.4
23.8
0.26
286
2300
(3006184) Hemoglobin [Mass/volume] in Capillary blood
36
162
2.28
4.91
2.1
2.1
g/l
137.5
125.1
1.51
22
123
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
11
24
4.63
4.79
1.0
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
305
2449
1.39
4.77
6.2
5.2
%
2.8
2.9
0.56
281
2274
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
102
2.60
4.75
1.2
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
40
191
2.15
4.75
4.3
4.6
mmol/l
2.1
2.4
0.36
28
125
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
33
3.99
4.72
1.2
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
33
3.99
4.72
1.2
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
33
3.99
4.72
1.2
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
33
3.99
4.72
1.2
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
174
1268
1.47
4.64
2.4
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
144
1012
1.51
4.59
1.6
1.7
mg/l
1.2
1.7
1.47
105
814
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
111
2.48
4.50
1.9
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
93
2.63
4.50
1.8
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
55
303
1.87
4.42
2.6
3.1
e9/l
4.0
4.2
0.16
28
216
(3010421) pH of Blood
43
218
2.03
4.39
4.4
4.4
ph
7.4
7.4
0.84
38
185
(3017569) Oxygen content in Arterial blood
15
46
3.30
4.20
2.2
1.8
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
11
27
4.12
4.17
1.0
1.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
298
2429
1.36
4.11
6.1
5.3
%
60.4
60.2
0.08
272
2262
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
104
2.45
4.09
1.3
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
353
2957
1.34
4.04
7.6
8.0
e9/l
5.0
4.6
1.67
304
2557
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
53
300
1.82
3.94
2.2
1.8
—
—
—
0
0
(3019977) pH of Arterial blood
15
49
3.10
3.82
2.0
2.6
ph
7.4
7.4
—
9
13
(3003338) MCHC [Mass/volume]
316
3732
0.75
3.81
34.8
27.3
g/l
330.3
331.3
1.10
306
3669
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
104
716
1.52
3.65
12.7
9.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
26
3.88
3.53
1.3
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
26
3.88
3.53
1.3
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
76
492
1.60
3.49
1.3
1.2
u/ml
13.9
16.3
0.09
23
167
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
56
335
1.72
3.48
2.5
1.9
—
—
—
0
0
(3019225) pH of Specimen
93
632
1.53
3.47
5.0
4.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
102
2.29
3.31
1.3
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
178
1.95
3.23
2.1
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
28
3.60
3.20
1.4
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
100
703
1.48
3.18
3.1
2.5
ug/l
7.0
6.7
0.07
80
600
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
99
2.26
3.08
9.3
5.2
iu/ml
1126.0
418.2
—
5
15
(44790048)
17
68
2.53
3.05
2.9
1.5
—
—
—
0
0
(44790047)
17
68
2.53
3.05
2.9
1.5
—
—
—
0
0
(44806118)
17
68
2.53
3.05
2.9
1.5
—
—
—
0
0
(44790049)
17
68
2.53
3.05
2.9
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
10
29
3.48
3.05
1.3
1.3
ug/l
2.0
7.8
—
5
10
(3013707) Erythrocyte sedimentation rate by Westergren method
424
3745
1.27
2.96
5.8
3.9
mm/h
17.8
16.0
1.22
390
3390
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
76
2.40
2.91
2.2
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
102
2.19
2.89
3.3
3.1
%
59.2
61.5
0.26
22
102
(40761535) Cells panel - Urine sediment
77
524
1.52
2.88
3.7
3.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
32
173
1.88
2.80
2.7
2.4
%
16.6
15.4
0.85
20
84
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
98
2.17
2.72
2.9
2.5
e9/l
5.6
4.9
0.30
21
98
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
343
2981
1.26
2.65
6.1
6.1
umol/l
15.4
13.7
0.57
319
2820
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
18
80
2.28
2.62
1.1
1.1
u/ml
6.4
2.0
—
6
6
(3013512) EKG study
222
1835
1.29
2.58
6.1
4.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
327
2843
1.25
2.48
14.6
13.5
inr
1.5
1.5
0.31
104
772
(1761868) Lipid panel - Serum or Plasma
83
1132
0.70
2.42
3.9
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
91
1213
0.72
2.31
3.1
3.3
mmol/l
2.5
2.4
4.21
81
1048
(3042733) HLA Ab [Presence] in Serum
5
9
5.58
2.21
6.2
6.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
39
243
1.63
2.17
2.6
3.0
g/l
0.9
0.3
0.60
14
101
(3014271) Vancomycin [Susceptibility]
13
55
2.39
2.13
2.6
2.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
49
2.47
2.11
1.2
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
300
2622
1.23
2.09
6.9
4.6
ng/l
62.9
70.3
0.18
250
2118
(3005719) IgG [Mass/volume] in Serum or Plasma
49
329
1.52
2.01
1.9
2.6
g/l
11.4
11.6
0.09
42
293
(3024932) HLA-DR beta [Type]
5
11
4.57
1.94
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
338
3764
0.83
1.94
30.2
24.6
%
14.3
14.1
1.40
328
3657
(3004616) Nuclear Ab [Presence] in Serum
11
45
2.46
1.93
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
39
2.58
1.92
2.1
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
313
2767
1.21
1.91
7.3
6.3
mmol/l
1.2
1.2
0.39
275
2464
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
54
375
1.47
1.90
1.7
1.8
ug/l
0.6
2.7
1.14
43
318
(3021901) Oxygen saturation in Capillary blood
29
176
1.67
1.81
4.1
2.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
85
646
1.35
1.81
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
23
3.06
1.80
1.1
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
60
2.19
1.78
1.3
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
41
2.46
1.76
1.1
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
309
2751
1.20
1.72
3.5
3.1
u/l
71.2
63.4
0.48
268
2488
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
48
2.31
1.71
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
31
195
1.61
1.71
3.2
3.2
nmol/l
0.7
0.9
2.74
20
151
(3023520) Reticulocytes [#/volume] in Blood
94
734
1.32
1.68
2.4
2.3
e9/l
71.8
64.6
1.20
72
588
(3009508) Creatinine [Moles/volume] in Urine
209
1797
1.22
1.67
3.6
3.2
mmol/l
7.3
7.5
0.35
170
1460
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
76
1.99
1.65
1.0
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
254
2229
1.20
1.64
4.7
4.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
187
1595
1.22
1.61
3.6
3.2
umol/l
396.3
9148.9
6.81
142
1330
(3000494) Fungus identified in Specimen by Culture
76
581
1.34
1.58
1.8
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
20
3.01
1.58
2.5
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
95
1188
0.77
1.57
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
64
477
1.37
1.56
5.7
4.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
293
3259
0.84
1.56
4.8
5.0
%
23.0
22.4
0.29
160
1770
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
85
1.90
1.55
1.1
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
84
655
1.31
1.53
1.7
2.5
g/l
67.5
65.7
1.38
72
588
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
21
2.87
1.50
2.2
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
16
3.14
1.44
1.0
1.7
—
—
—
0
0
(44813793)
5
16
3.14
1.44
1.2
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
210
1832
1.20
1.43
2.6
2.1
u/l
213.9
288.2
0.54
191
1696
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
15
81
1.87
1.40
1.4
1.5
u/l
12.0
14.3
1.35
15
76
(3000330) Specific gravity of Urine by Test strip
21
335
0.62
1.39
3.3
4.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
59
445
1.35
1.36
1.6
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
332
3626
0.86
1.35
6.0
4.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
37
0.00
1.34
0.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
31
208
1.51
1.34
4.2
2.8
kpa
7.7
7.5
0.19
31
185
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
128
1.66
1.34
1.1
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
203
1780
1.19
1.31
2.9
2.5
u/l
59.5
56.7
0.34
179
1646
(3006462) Nitrate [Presence] in Urine
6
24
2.51
1.30
4.7
3.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
9
172
0.52
1.30
5.2
3.9
mmol/l
7.4
7.7
—
9
167
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
169
1.56
1.30
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
169
1.56
1.30
1.3
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
125
1047
1.23
1.30
2.9
2.7
g/l
2.3
2.2
1.65
110
968
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
119
993
1.23
1.28
3.0
2.8
%
20.2
22.2
0.89
93
858
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
35
2.30
1.27
1.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
8
36
2.23
1.24
2.0
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
63
1.92
1.23
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
204
1799
1.18
1.23
3.8
3.3
mg/l
372.5
265.8
0.15
135
1260
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
19
2.64
1.21
1.4
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
69
544
1.29
1.20
1.8
2.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
167
1452
1.19
1.18
4.8
4.2
estimate
0.0
0.0
0.00
51
445
(3026008) Bacteria identified in Urine by Culture
156
1793
0.84
1.18
3.5
3.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
133
1.59
1.18
1.0
1.1
iu/ml
43.1
138.1
—
8
46
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
457
1.31
1.17
3.9
4.6
ng/l
101.1
116.7
0.64
52
390
(3044242) Glucose [Moles/volume] in Arterial blood
10
50
2.01
1.17
1.7
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
10
183
0.54
1.13
4.9
3.8
mmol/l
1.2
1.7
—
10
178
(3028026) IgM [Mass/volume] in Serum or Plasma
37
268
1.40
1.12
1.2
1.9
g/l
1.0
1.7
1.45
32
238
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
104
869
1.23
1.12
2.3
1.8
—
—
—
0
0
(3020891) Body temperature
40
294
1.38
1.12
8.0
4.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
398
3710
1.14
1.11
5.6
4.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
31
2.27
1.10
1.3
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
1.3
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
74
1.77
1.07
1.1
2.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
330
3046
1.14
1.06
8.0
7.2
mmol/l
1.2
1.2
0.30
258
2514
(3031040) Bacteria [#/volume] in Urine by Automated count
397
3709
1.14
1.05
5.9
5.0
e6/l
4.4
2111.0
—
5
93
(3022948) Iron [Moles/volume] in Serum or Plasma
134
1156
1.19
1.05
2.8
2.7
umol/l
11.7
11.8
0.09
115
1071
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
43
324
1.35
1.04
4.0
4.2
mmol/l
24.7
23.5
1.64
37
291
(40760892) CBC W Ordered Manual Differential panel - Blood
114
973
1.20
1.01
4.5
4.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
35
2.01
1.00
1.1
1.1
—
88.6
—
0
7
(3051387) C reactive protein [Mass/volume] in Capillary blood
10
175
0.57
0.99
4.2
3.9
mg/l
19.5
31.9
—
5
129
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.9
—
58.0
—
0
24
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
30
0.00
0.97
0.0
1.1
—
11.2
—
0
10
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
3.2
—
93.0
—
0
30
(3020682) Albumin/Creatinine [Ratio] in Urine
213
1920
1.15
0.96
4.6
4.0
mg/mmol
14.0
12.9
0.09
138
1314
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
77
1.70
0.95
3.6
2.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
41
312
1.33
0.95
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
419
1.28
0.94
3.6
3.0
—
—
—
0
0
(4062490)
6
27
2.23
0.93
1.2
1.0
—
—
—
0
0
(4211845)
6
28
2.15
0.91
4.7
3.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
871
1.20
0.91
2.2
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
42
1.91
0.88
1.1
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
255
1.35
0.88
1.1
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
8
43
1.87
0.87
2.5
1.7
mmol/l
7.6
7.1
—
8
31
(3022621) pH of Urine by Test strip
30
400
0.74
0.85
2.8
3.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
354
1.29
0.85
1.8
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
88
1.60
0.84
1.2
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
104
897
1.18
0.84
2.5
3.4
u/l
242.6
246.7
0.17
98
838
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
16
105
1.53
0.82
1.4
1.4
u/l
367.5
300.7
0.25
16
100
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
92
1069
0.84
0.81
4.0
3.4
e6/l
0.7
0.8
0.13
52
681
(3027945) Reticulocytes/100 erythrocytes in Blood
115
1004
1.17
0.81
2.3
2.2
%
1.8
1.7
0.36
98
879
(3000991) Gas panel - Venous blood
71
594
1.21
0.80
7.1
8.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
114
1.50
0.80
1.0
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
33
1.82
0.79
1.7
1.2
%
19.5
23.8
—
6
24
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
66
1.68
0.79
1.4
1.3
%
49.8
71.0
—
5
45
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
66
1.68
0.79
1.0
1.4
—
109.8
—
0
14
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
53
1.71
0.75
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
75
1.61
0.75
1.6
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
58
480
1.22
0.74
1.9
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
445
4653
0.91
0.73
5.8
5.3
mmol/l
2.3
2.3
0.58
376
4114
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
438
4181
1.10
0.70
8.9
7.6
u/l
89.9
84.9
0.69
408
3899
(4094501)
14
93
1.51
0.69
1.2
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
205
1883
1.12
0.69
2.5
2.2
mg/l
3.6
3.0
1.57
163
1606
(3021440) Promyelocytes/100 leukocytes in Blood
52
429
1.23
0.69
3.5
3.7
%
0.2
0.1
0.42
17
159
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
65
549
1.20
0.68
2.1
2.1
g/l
0.2
0.2
1.44
56
498
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
69
1.60
0.68
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.86
0.68
1.6
3.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
27
1.86
0.68
1.6
3.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
59
1.53
0.68
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
55
457
1.22
0.68
3.5
3.7
%
0.9
0.9
0.02
18
172
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
47
385
1.23
0.67
1.6
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
16
111
1.45
0.66
1.8
1.8
%
85.4
89.1
0.87
16
111
(3002179) Metamyelocytes/100 leukocytes in Blood
49
404
1.23
0.66
3.4
3.6
%
0.3
0.6
0.88
13
122
(3012441) Differential panel - Pleural fluid
18
128
1.42
0.66
1.7
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
10
62
1.62
0.65
1.0
1.1
u/ml
282.0
282.6
—
5
31
(3003434) Protein [Mass/volume] in Pleural fluid
22
163
1.36
0.65
1.5
1.5
g/l
35.4
30.4
1.35
22
148
(3028308) Erythrocytes [#/volume] in Pleural fluid
18
129
1.40
0.64
1.6
1.4
e6/l
415052.4
69092.0
0.53
11
81
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
138
1.39
0.63
1.4
1.5
ug/g
277.6
241.0
0.39
12
91
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
79
1.53
0.63
1.2
1.3
—
—
—
0
0
(4146454)
11
71
1.56
0.62
1.7
2.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
63
1.59
0.62
1.3
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
30
1.67
0.61
1.6
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
113
1.42
0.61
1.4
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
97
1093
0.87
0.61
3.5
3.2
e6/l
1.4
1.0
0.71
56
701
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
6.9
—
27.4
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
6.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
64
1.57
0.58
1.3
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
283
2666
1.09
0.58
5.3
5.0
g/l
32.6
33.7
2.53
246
2468
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
8
53
1.51
0.58
1.3
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
23
0.00
0.58
0.0
1.8
—
8.8
—
0
14
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
112
0.62
0.58
3.6
2.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
51
429
1.20
0.58
1.6
1.5
—
—
—
0
0
(4306422)
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
508
5245
0.92
0.57
38.1
29.2
e9/l
7.6
7.2
2.00
484
5019
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
65
1.55
0.55
1.3
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
508
5242
0.92
0.55
37.9
29.1
pg
30.6
30.6
0.49
489
5094
(3000963) Hemoglobin [Mass/volume] in Blood
508
5242
0.92
0.55
38.3
29.4
g/l
132.8
131.3
1.29
489
5096
(3007461) Platelets [#/volume] in Blood
508
5242
0.92
0.55
38.1
29.2
e9/l
229.8
222.1
1.78
485
5047
(3026361) Erythrocytes [#/volume] in Blood
508
5242
0.92
0.55
38.1
29.2
e12/l
4.4
4.3
1.94
480
5024
(3024731) MCV [Entitic volume]
508
5241
0.92
0.55
37.9
29.1
fl
92.4
92.4
0.08
488
5095
(3023199) Leukocytes [#/volume] in Pleural fluid
19
142
1.35
0.54
1.6
1.4
e6/l
1143.7
1915.3
0.94
14
103
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
432
4485
0.92
0.54
24.0
19.6
ml/min/173m2
66.3
67.2
0.36
373
3781
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
432
4485
0.92
0.54
5.4
4.7
mmol/l
3.9
4.1
1.66
366
4007
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
215
2007
1.10
0.54
2.4
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
437
4534
0.92
0.54
7.8
7.0
mmol/mol
42.3
42.0
0.33
363
4072
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
19
249
0.76
0.53
1.5
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
62
1.46
0.53
1.0
1.1
g/l
1.6
1.7
—
9
56
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
39
1.54
0.53
2.0
2.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
66
1.52
0.52
1.3
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
234
2197
1.09
0.52
3.2
2.9
ug/l
174.9
183.7
0.24
199
1974
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
83
1.45
0.52
6.4
4.9
—
—
—
0
0
(3035880) pH of Pleural fluid
9
64
1.41
0.51
1.0
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
236
0.76
0.51
1.2
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
203
1896
1.09
0.51
2.2
2.1
nmol/l
80.5
77.6
0.75
167
1606
(3045424) Erythrocytes [Presence] in Urine
9
65
1.39
0.50
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
67
1.50
0.50
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
67
1.50
0.50
1.3
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
427
4423
0.93
0.49
5.5
4.7
mmol/l
1.3
1.3
1.98
359
3895
(3036481) Cortisol [Moles/volume] in Serum or Plasma
47
402
1.18
0.47
2.3
2.1
nmol/l
373.7
372.5
0.01
40
356
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
85
1.42
0.47
3.9
3.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
59
515
1.16
0.46
3.7
3.8
mmol/l
1.2
1.2
0.25
52
449
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
94
1.39
0.46
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
85
0.59
0.45
1.4
1.4
e6/l
5.8
601.4
—
5
73
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
214
2270
0.92
0.45
3.2
3.4
ug/l
0.9
0.9
0.08
159
1660
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
50
432
1.17
0.45
3.5
3.3
ml/min/173m2
56.8
56.6
0.02
25
198
(3002256) Pathology report gross observation
68
765
0.88
0.44
1.6
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
45
386
1.18
0.44
9.8
9.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
30
361
0.82
0.44
5.1
4.5
%
52.0
47.4
0.43
30
355
(4024509)
7
51
1.38
0.44
2.4
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
241
2541
0.93
0.44
4.5
4.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
81
727
1.13
0.44
3.6
3.1
ng/l
225.4
294.2
1.12
75
657
(3007164) IgA [Mass/volume] in Serum or Plasma
77
689
1.13
0.44
1.3
1.4
g/l
3.6
3.0
0.69
45
392
(3019309) Folate [Moles/volume] in Red Blood Cells
170
1588
1.09
0.43
2.0
1.9
nmol/l
1207.7
1145.2
0.41
112
1202
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
93
0.64
0.42
1.2
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
58
1.38
0.41
2.1
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
31
259
1.20
0.41
1.8
2.9
mg/l
34.4
93.0
0.71
26
219
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
59
1.36
0.41
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
508
5207
0.94
0.39
31.9
24.6
mmol/l
4.1
4.1
1.72
486
5034
(1761482) Bacteria [#/volume] in Urine by Culture
17
215
0.79
0.39
3.6
4.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
23
187
1.24
0.39
1.8
3.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
23
187
1.24
0.39
1.1
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
178
1.24
0.39
2.5
2.4
ug/min
58.2
109.2
—
10
110
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
508
5205
0.94
0.39
32.0
24.4
mmol/l
139.3
139.6
1.79
488
5032
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
494
5066
0.94
0.39
13.4
11.0
u/l
25.1
24.9
0.06
464
4802
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
455
4678
0.94
0.39
6.0
5.2
mmol/l
6.2
6.2
0.03
382
4094
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
80
1.38
0.38
1.5
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
36
1.39
0.38
1.6
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
102
937
1.10
0.38
6.2
6.0
mmol/l
1.0
1.0
0.20
94
858
(4034850)
12
158
0.76
0.37
35.7
14.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
17
134
1.27
0.37
1.9
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
160
1701
0.93
0.36
1.8
1.7
nmol/l
19.1
18.8
0.10
135
1456
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
226
1.20
0.36
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
209
2196
0.94
0.35
13.8
10.5
e9/l
0.0
0.0
0.02
167
1783
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
414
4259
0.94
0.35
4.7
4.0
mu/l
2.2
2.1
0.45
352
3705
(4035726)
40
457
0.87
0.34
1.3
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
73
1.37
0.34
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
44
1.37
0.34
1.0
18.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
1.3
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
92
1.31
0.32
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
52
1.35
0.31
1.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
52
1.35
0.31
1.6
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
96
0.73
0.31
1.7
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
211
2016
1.06
0.31
2.5
2.1
—
—
—
0
0
(3017704) Immunofixation for Urine
7
53
1.32
0.31
1.0
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
138
1301
1.07
0.30
5.6
4.2
ng/l
273.3
332.8
0.19
117
1166
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
163
1546
1.07
0.30
3.8
3.0
u/l
34.0
37.3
0.38
153
1480
(3025159) Blasts/100 leukocytes in Blood
44
392
1.13
0.29
3.7
3.8
%
0.1
0.2
0.69
15
131
(3048689) Calprotectin [Mass/mass] in Stool
37
326
1.14
0.29
1.8
2.1
ug/g
105.7
193.2
1.61
23
265
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
139
1.23
0.29
1.1
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
13
103
1.27
0.28
2.2
2.3
%
63.2
61.2
0.09
13
103
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
129
0.77
0.28
1.3
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
77
711
1.09
0.28
5.2
4.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
77
711
1.09
0.28
8.7
7.0
mmol/l
13.4
12.8
0.27
70
673
(3024928) Oxygen saturation in Venous blood
17
140
1.22
0.27
2.0
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
118
0.76
0.27
2.1
2.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
128
1354
0.94
0.27
4.4
3.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
65
707
0.91
0.27
2.3
4.0
ug/l
19.2
36.5
0.53
54
587
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
67
1.20
0.26
1.3
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
52
473
1.11
0.26
2.8
2.5
u/l
37.5
36.0
0.12
46
390
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
72
1.25
0.25
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
73
1.24
0.25
1.6
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
395
4043
0.96
0.25
6.0
5.8
ug/l
6.2
5.2
0.14
319
3535
(3003327) Ova and parasites identified in Stool by Light microscopy
11
87
1.27
0.24
1.8
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
227
1.15
0.24
1.5
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
11
136
0.81
0.23
2.1
2.1
%
90.5
83.5
0.59
11
129
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
142
1487
0.95
0.23
1.7
1.8
pmol/l
438.5
4680210.5
0.50
98
1218
(3022217) INR in Platelet poor plasma by Coagulation assay
115
1211
0.94
0.22
33.2
33.0
inr
1.2
1.6
—
7
175
(3017446) Testosterone [Moles/volume] in Serum or Plasma
57
526
1.09
0.22
2.2
2.2
nmol/l
9.8
11.1
0.62
46
442
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
105
1108
0.94
0.22
1.8
1.6
mmol/l
1.3
1.2
0.36
83
897
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
11
0.00
0.21
0.0
3.4
—
2166.4
—
0
11
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.9
—
102.1
—
0
10
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
96.4
—
0
10
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
120
1142
1.06
0.21
4.7
4.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.5
—
17.8
—
0
13
(37021550) Renin [Units/volume] in Plasma --upright
0
13
0.00
0.21
0.0
1.4
—
42.0
—
0
7
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
184
1774
1.05
0.20
4.5
4.1
ph
7.4
7.4
0.36
44
344
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
14
117
1.20
0.20
1.2
1.3
g/l
1.1
1.1
0.29
14
112
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
122
0.82
0.19
2.0
1.6
—
—
—
0
0
(3026782) Osmolality of Urine
135
1407
0.95
0.19
4.3
3.0
mosm/kgh2o
579.6
585.6
0.13
117
1198
(3035350) Ketones [Presence] in Urine by Test strip
255
2482
1.04
0.19
4.5
4.0
estimate
0.0
0.0
0.00
66
501
(3015377) Calcium [Moles/volume] in Serum or Plasma
190
1961
0.96
0.18
3.2
3.3
mmol/l
2.3
2.3
0.99
160
1683
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
59
1.19
0.18
1.0
1.3
u/ml
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
60
1.17
0.18
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
32
351
0.91
0.17
1.5
1.5
%
1.5
1.8
2.49
24
270
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
39
359
1.09
0.17
1.7
1.5
—
—
—
0
0
(1002224) Polysomnography panel
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
105
1005
1.05
0.16
4.5
3.0
mmol/l
0.8
0.8
0.33
98
926
(3002582) Erythrocytes [#/volume] in Urine
199
2046
0.96
0.16
4.6
3.7
e6/l
326.2
135.5
0.34
157
1683
(3044640) Blood type and Crossmatch panel - Blood
183
1884
0.96
0.15
2.4
2.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
78
0.77
0.15
1.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
20
224
0.89
0.15
1.6
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
488
1.07
0.15
1.7
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
424
4300
0.97
0.14
4.8
4.2
mmol/l
1.2
1.2
0.42
356
3758
(3036782) Glucose [Moles/volume] in Pleural fluid
13
112
1.16
0.14
1.2
1.5
mmol/l
7.2
6.5
0.32
13
106
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
417
0.93
0.13
1.7
1.7
g/l
1.6
1.5
0.30
31
355
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
200
1.10
0.12
1.8
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
114
1.14
0.12
1.8
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
114
1.14
0.12
1.8
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
146
1421
1.03
0.11
2.3
2.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
218
2223
0.97
0.11
5.2
4.1
e6/l
272.1
124.4
0.44
159
1762
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
291
0.93
0.11
2.3
2.6
g/l
12.2
11.0
0.60
22
244
(3021788) Differential panel - Synovial fluid
12
105
1.14
0.11
1.5
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
355
3503
1.02
0.11
6.6
5.2
mmol/l
6.9
7.0
0.20
337
3328
(42529406) Shigella sp [Presence] in Stool by Culture
13
115
1.13
0.10
1.8
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
11
96
1.15
0.10
3.7
6.2
mg/l
11.1
12.4
0.54
11
91
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
45
1.11
0.10
1.4
1.3
nmol/l
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
1.0
1.6
mg/l
3.3
5.6
—
5
42
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
33
350
0.94
0.09
2.7
2.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
191
1946
0.98
0.09
4.9
4.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
175
1716
1.03
0.09
4.5
3.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
57
1.05
0.08
2.7
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
215
0.93
0.07
1.6
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
72
0.83
0.07
6.7
3.3
umol/l
310.0
331.0
—
6
60
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
108
1.11
0.07
1.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
92
0.87
0.06
1.3
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
187
1.07
0.06
3.9
3.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
315
0.95
0.06
2.2
2.5
g/l
4.0
3.8
0.36
21
219
(3045414) Leukocytes [Presence] in Urine
21
197
1.07
0.06
1.7
2.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
63
648
0.97
0.06
2.8
2.7
umol/l
19.0
11.3
0.76
58
575
(3030467) Casts [#/volume] in Urine by Automated count
179
1813
0.98
0.05
4.5
3.6
e6/l
0.5
0.5
0.01
137
1469
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
70
717
0.97
0.05
1.2
1.1
u/ml
1.5
1.9
0.18
15
157
(40768800) Prostate Pathology biopsy report
24
252
0.95
0.05
1.1
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
408
4058
1.01
0.04
25.2
22.1
%
37.1
37.3
0.11
194
2261
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
160
1.06
0.04
1.4
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
50
512
0.98
0.03
1.3
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
27
260
1.04
0.03
2.3
2.7
g/l
1.6
1.5
0.02
22
223
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
497
4952
1.01
0.03
27.6
20.2
mg/l
27.7
31.8
1.83
440
4215
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
236
2377
0.99
0.03
4.8
3.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
252
2503
1.01
0.03
4.7
4.0
estimate
0.0
0.0
0.00
64
477
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
290
1.04
0.03
2.2
2.5
g/l
3.2
3.1
0.30
21
223
(3042936) Bacteria identified in Isolate by Culture
91
923
0.98
0.03
2.0
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
330
1.03
0.03
2.3
2.4
u/ml
0.3
0.3
0.09
16
187
(3045788) Cell count panel - Pleural fluid
10
108
0.93
0.03
1.7
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
323
3244
0.99
0.02
3.9
3.1
pmol/l
15.4
15.1
1.04
277
2812
(40761511) CBC panel - Blood by Automated count
491
4924
0.99
0.02
26.7
19.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
70
690
1.02
0.02
3.9
4.0
mmol/l
3.3
1.8
2.63
58
527
(40758558) Short blood count panel - Blood
125
1261
0.99
0.02
7.4
6.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
123
1.06
0.01
1.9
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
246
2449
1.01
0.01
5.7
5.4
estimate
0.0
0.0
0.00
65
495
(3007853) Bacteria identified in Skin by Aerobe culture
73
722
1.01
0.01
1.7
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
150
1492
1.01
0.01
3.9
2.8
e6/l
3.2
3.3
0.07
136
1319
(3019150) Specific gravity of Urine by Refractometry
113
1124
1.01
0.00
5.1
4.6
kg/l
1.0
1.0
1.28
19
198
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
315
0.98
0.00
2.2
2.5
g/l
8.0
7.3
1.26
23
228
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
315
0.98
0.00
2.2
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
118
1.02
0.00
1.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
267
2667
1.00
0.00
2.2
2.2
pmol/l
93.5
89.2
0.72
145
1517
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
54
0.93
0.00
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.2
—
76.1
—
0
9
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
84
0.95
0.00
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
59
1.02
0.00
4.3
3.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
1849.5
—
0
8
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.8
—
79.2
—
0
6
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
9
92
0.98
0.00
1.2
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
95
0.95
0.00
1.0
1.1
—
14.1
—
0
5
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_ASBESTPNEUMOC and mortality.

Females

Parameter HR [95% CI] p-value
J10_ASBESTPNEUMOC 1.687 [1.26, 2.25] < 0.001
Birth year 0.998 [0.99, 1.01] 0.642

During the follow-up period (1.1.1998 — 31.12.2019), 117 out of 200 females with J10_ASBESTPNEUMOC died.

Males

Parameter HR [95% CI] p-value
J10_ASBESTPNEUMOC 1.879 [1.69, 2.09] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 2029 out of 3332 males with J10_ASBESTPNEUMOC died.

Mortality risk

Mortality risk for people of age

years, who have J10_ASBESTPNEUMOC.

N-year risk Females Males
1 0.176% 0.358%
5 1.034% 2.316%
10 2.786% 5.423%
15 5.368% 10.024%
20 9.573% 16.505%

Relationships between endpoints

↥

Index endpoint: J10_ASBESTPNEUMOC – Pneumoconiosis due to asbestos and other mineral fibres

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data